AE Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

AE Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.7K	Sell	90 -500	-85%	-$54.1K	﹤0.01%	2375
2026 Q1	$61.2K	Hold	590	–	–	﹤0.01%	1918
2025 Q4	$61.7K	Hold	590	–	–	﹤0.01%	1809
2025 Q3	$54.6K	Sell	590 -127	-18%	-$11.1K	﹤0.01%	1699
2025 Q2	$57.2K	Buy	717 +127	+22%	+$10.1K	﹤0.01%	1585
2025 Q1	$51.1K	Sell	590 -35	-6%	-$2.98K	﹤0.01%	1582
2024 Q4	$51.7K	Buy	+625	New	+$53.8K	﹤0.01%	1553
2019 Q2	–	Sell	-3,078	Closed	-$201K	–	994
2019 Q1	$201K	Buy	+3,078	New	+$202K	0.01%	594

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

AE Wealth Management's PJP Position: Q2 2026 in Review

AE Wealth Management reduced its Invesco Pharmaceuticals ETF (PJP) stake by 85% in Q2 2026, selling an estimated $54.1K and leaving 90 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2375.

AE Wealth Management first reported a position in PJP in Q1 2019 and has held it in 8 quarters since. The position peaked at $201K in Q1 2019. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

AE Wealth Management held 90 shares of Invesco Pharmaceuticals ETF worth $10.7K as of Q2 2026.
AE Wealth Management sold 500 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $54.1K.
Invesco Pharmaceuticals ETF made up ﹤0.01% of AE Wealth Management's portfolio in Q2 2026, its #2375 holding.
AE Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q1 2019 and has held it in 8 quarters since.
AE Wealth Management's Invesco Pharmaceuticals ETF position peaked at $201K in Q1 2019.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on AE Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.